Pharmacokinetics of P24 Antibody (Ab) in HIV+ Pregnant Women & Newborns Receiving Hyperimmune HIV Immunoglobulin (HIVIG) in ACTG Protocol 185
Authors
Lynne M. Mofenson
Safety and Pharmacokinetics of Hyperimmune HIV Immunoglobulin (HIVIG) in HIV+ Pregnant Women and Newborns
Authors
John S. Lambert
AIDS Clinical Trials Group (ACTG) Protocol 219: A PediatricHIV Late Outcomes Protocol
Authors
James M. Oleske, Mary Glenn Fowler, Michael T. Brady
Enhancing the Prognostic Value of Bodily Growth Histories in HIV-Positive Pediatric Cohorts
Authors
Vincent J. Carey
Perinatal AIDS Clinical trials - Integrating Research Into Primary Care "The Miami Experience"
Authors
Faith Doyle
The Enrollment of HIV Infected Adolescents in Clinical Trials: The Experience of ACTG Protocol 220
Authors
Lawrence D'Angelo
Quality of Life Outcomes in Children 6 Months to 4 Years of Age Born of Women Enrolled in a Perinatal HIV Transmission Clinical Trial
Authors
Colleen Clark
Interkit Differences in Plasma HIV-1 RNA Levels in Mothers Enrolled in WITS/ACTG 076
Authors
Donald J. Brambilla
Placental Transfer of Didanosine (ddI) and Initial Evaluation of Didanosine Toxicity in HIV-1 Infected Pregnant Women and their Offspring
Authors
Elizabeth Livingston, Sheran Patel, Jashvant D. Unadkat, Ross E. McKinney, Arlene D. Bardeguez, Mary Jo O'Sullivan
Prognostic Value of Plasma RNA, CD4 and Growth Markers for Clinical Disease Progression in Children with HIV Disease
Authors
Florence H. Yong, Kenneth Stanley, Ross E. McKinney, Stephen A. Spector, J. Louise Martin-Carpenter, George M. Johnson, Wendy G Mitchell, Karen J. O'Donnell, Pim Brouwers, Lynne M. Mofenson, Janice Hodge
